FLAG Regimen with or without Idarubicin in Children with Relapsed/Refractory Acute Leukemia: Experience from a Turkish Pediatric Hematology Center

OBJECTIVE: The optimal therapy to achieve higher rates of survival in pediatric relapsed/refractory acute leukemia (AL) is still unknown. In developing countries, it is difficult to obtain some of the recent drugs for optimal therapy and mostly well-known drugs proven to be effective are used. We as...

Descripción completa

Detalles Bibliográficos
Autores principales: Yılmaz Bengoa, Şebnem, Ataseven, Eda, Kızmazoğlu, Deniz, Demir Yenigürbüz, Fatma, Erdem, Melek, Ören, Hale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451688/
https://www.ncbi.nlm.nih.gov/pubmed/27095144
http://dx.doi.org/10.4274/tjh.2015.0411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451688/
https://www.ncbi.nlm.nih.gov/pubmed/27095144
http://dx.doi.org/10.4274/tjh.2015.0411

Ejemplares similares